N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis [NA]